Delivery Order SPE2DB20D3101-SPE2DB25FRVT0
Award Date 9/17/25
Potential Completion Date 10/8/25
Potential Value $5.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency for 120 tablets of Bosulif 100 mg, a pharmaceutical product used in cancer treatment. This firm fixed-price delivery order, awarded on August 12, 2025, carries a ceiling value of $5,704.45 and is scheduled for completion by September 3, 2025. The contract involves no set-aside designation, indicating AmerisourceBergen Drug Corp won the award through open competition. Performance will be fulfilled at...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Bosulif 500 mg tablets (30-count units) under a firm fixed-price contract. The order carries a ceiling value of $11,301.40 and is scheduled for completion by September 25, 2025. This is a competitively awarded, non-set-aside delivery order with performance directed to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents...
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Bosulif 100 mg tablets (120-count units) with a contract ceiling value of $5,704.45. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to this established pharmaceutical distributor. The delivery order carries an ultimate completion date of October 2, 2025, and will be fulfilled from...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Bosulif 100 mg tablets (120-count units) with a ceiling value of $5,704.45. This firm fixed-price delivery order is scheduled for completion by August 22, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's capability...
- The Defense Logistics Agency awarded a $11,815.63 delivery order to AmerisourceBergen Drug Corp for the supply of Bosulif 400 mg tablets (30-count units) under a firm fixed price contract type. The delivery order was competitively awarded without a set-aside designation and carries an ultimate completion date of July 24, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply transaction. This delivery order is...
- The Defense Logistics Agency awarded a $11.4K firm fixed price delivery order to AmerisourceBergen Drug Corp for 120 tablets of Bosulif 100 mg, a pharmaceutical product used in cancer treatment. The delivery order was competitively awarded without set-aside provisions and carries an ultimate completion date of August 27, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement needs,...
- The Defense Logistics Agency awarded a $11,815.63 delivery order to AmerisourceBergen Drug Corp for BOSULIF 400 mg tablets (30-count units) on September 2, 2025, with an ultimate completion date of September 23, 2025. This firm fixed-price contract, utilizing no set-aside designation, represents a competitive award under the company's broader pharmaceutical supply agreements with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- AmerisourceBergen Drug Corp was awarded a competitively bid delivery order valued at $23,631.26 for BOSULIF 400 mg tablets (30-count packages) by the Defense Logistics Agency Medical Supply Chain on August 20, 2025, with an ultimate completion date of September 11, 2025. The contract employs firm fixed-price pricing with no set-aside designation, and performance will be executed from the contractor's Conshohocken, Pennsylvania location. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $23,631.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Bosulif 400 mg tablets (30-count units). The contract, which has no set-aside designation, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 25, 2025. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,523.71 firm fixed-price delivery order is for the provision of 120 tablets of the medication BOSULIF 100 MG. The contract has an ultimate completion date of March 25, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...